Subclinical myocardial dysfunction in normoglycemic first-degree relatives of patients with type 2 diabetes mellitus: Associations with Endothelin-1, E-selectin, and Endocan
Diabetes & Vascular Disease Research · 2025
DOI: 10.1177/14791641251407690 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes & Vascular Disease Research, 2025. Verfasst von İsmet Çulcuoğlu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Atatürk Training and Research Hospital, İzmir Katip Çelebi University, İzmir, Türkiye. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Endothelin-1, E-Selectin, Proteoglycans. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background
First-degree relatives (FDRs) of individuals with type 2 diabetes mellitus (T2DM) are at increased cardiometabolic risk due to genetic predisposition, even in the absence of overt disease. To evaluate subclinical myocardial dysfunction using speckle-tracking echocardiography (STE) and to assess serum levels of endothelial dysfunction related biomarkers, Endothelin-1 (ET-1), E-selectin, and Endocan, in normoglycemic FDRs of patients with T2DM, compared with healthy controls.
Methods
This study included 151 normoglycemic participants, comprising 75 individuals in the study group and 76 in the control group. Global longitudinal and circumferential strain values were assessed using STE. Serum levels of ET-1, E-selectin, and Endocan were measured using ELISA.
Results
ET-1 levels were significantly higher in the study group (p = 0.047). STE revealed lower strain values in the study group in both SAX Basal/Mid/Apical (p = 0.027) and A4C/A2C/A3C mean views (p = 0.013). E-selectin showed a negative correlation with myocardial strain values, although no significant between-group difference was observed.
Conclusions
Normoglycemic FDRs of T2DM patients exhibited subclinical myocardial strain abnormalities and elevated ET-1 levels, suggesting early cardiovascular alterations associated with genetic predisposition. ET-1 and E-selectin may serve as potential biomarkers for preclinical myocardial dysfunction in at-risk individuals.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, Atatürk Training and Research Hospital, İzmir Katip Çelebi University, İzmir, Türkiye.
- Department of Endocrinology and Metabolism, Atatürk Training and Research Hospital, İzmir Katip Çelebi University, İzmir, Türkiye.
- Department of Internal Medicine, Biga State Hospital, Çanakkale, Türkiye.
- Department of Biochemistery, Karabük Public Health Laboratory, Karabük, Türkiye.
- Department of Internal Medicine, Internal Medicine and Wellness Clinic, İzmir, Türkiye.
- Department of Biochemistery, Atatürk Training and Research Hospital, İzmir Katip Çelebi University, İzmir, Türkiye.
ORCID-Profile: İsmet Çulcuoğlu, Mert Üğe, Yusuf Üzüm, Volkan Emren
Zitieren
APA
Çulcuoğlu, İ., Pamuk, B. Ö., Eğlenoğlu, G., Üğe, M., Üzüm, Y., Erbak Yılmaz, H., Esen, Ş., & Emren, V. (2025). Subclinical myocardial dysfunction in normoglycemic first-degree relatives of patients with type 2 diabetes mellitus: Associations with Endothelin-1, E-selectin, and Endocan. Diabetes & Vascular Disease Research. https://doi.org/10.1177/14791641251407690
Vancouver
Çulcuoğlu İ, Pamuk BÖ, Eğlenoğlu G, Üğe M, Üzüm Y, Erbak Yılmaz H, et al. Subclinical myocardial dysfunction in normoglycemic first-degree relatives of patients with type 2 diabetes mellitus: Associations with Endothelin-1, E-selectin, and Endocan. Diabetes & Vascular Disease Research. 2025. doi:10.1177/14791641251407690
BibTeX
@article{ulcuolu2025,
author = {Çulcuoğlu, İsmet and Pamuk, Barış Önder and Eğlenoğlu, Gökçe and Üğe, Mert and Üzüm, Yusuf and Erbak Yılmaz, Huriye and Esen, Şaban and Emren, Volkan},
title = {Subclinical myocardial dysfunction in normoglycemic first-degree relatives of patients with type 2 diabetes mellitus: Associations with Endothelin-1, E-selectin, and Endocan},
journal = {Diabetes & Vascular Disease Research},
year = {2025},
doi = {10.1177/14791641251407690}
}
EUVIMED